newsfilter
← Latest News
ClinicalTrials.gov·

Phase 2 Safety and Efficacy Study of PRA023 in Subjects With Systemic Sclerosis Associated With Interstitial Lung Disease (SSc-ILD) - NCT05270668

Incidence of AE, SAE and AE leading to discontinuation, Annual change of forced vital capacity (FVC), Change of FVC, (and 3 more...)